IPTACOPAN FOR THE TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME Application WO-2022234541-A1 World Intellectual Property Organisation (WIPO) 10 Nov 2022
Anti-C5 antibodies having improved pharmacokinetics Grant US-11434280-B2 United States of America 06 Sep 2022
High concentration anti-C5 antibody formulations Grant US-11365241-B2 United States of America 21 Jun 2022
Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal… Grant US-10584164-B2 United States of America 10 Mar 2020